Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes

Sadia Zafar; Dafne Carolina Alves Quixabeira; Tatiana Viktorovna Kudling; Victor Cervera-Carrascon; Joao Manuel Santos; Susanna Grönberg-Vähä-Koskela; Fang Zhao; Pasi Aronen; Camilla Heiniö; Riikka Havunen; Suvi Sorsa; Anna Kanerva; Akseli Hemminki

doi:10.1038/s41417-020-00226-z

Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes

Sadia Zafar, Dafne Carolina Alves Quixabeira, Tatiana Viktorovna Kudling, Victor Cervera-Carrascon, Joao Manuel Santos, Susanna Grönberg-Vähä-Koskela, Fang Zhao, Pasi Aronen, Camilla Heiniö, Riikka Havunen, Suvi Sorsa, Anna Kanerva, Akseli Hemminki

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Lehti	Cancer Gene Therapy
Vuosikerta	28
Numero	5
Sivut	442-454
Sivumäärä	13
ISSN	0929-1903
DOI - pysyväislinkit	https://doi.org/10.1038/s41417-020-00226-z
Tila	Julkaistu - toukok. 2021
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

3122 Syöpätaudit
3111 Biolääketieteet
318 Lääketieteen bioteknologia
11832 Mikrobiologia ja virologia
1184 Genetiikka, kehitysbiologia, fysiologia

Pääsy asiakirjaan

10.1038/s41417-020-00226-z

s41417-020-00226-zLopullinen julkaistu versio, 1,8 MBLisenssi: CC BY

Siteeraa tätä

Zafar, S., Quixabeira, D. C. A., Kudling, T. V., Cervera-Carrascon, V., Santos, J. M., Grönberg-Vähä-Koskela, S., Zhao, F., Aronen, P., Heiniö, C., Havunen, R., Sorsa, S., Kanerva, A., & Hemminki, A. (2021). Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes. Cancer Gene Therapy, 28(5), 442-454. https://doi.org/10.1038/s41417-020-00226-z

@article{03db0da2a4e04dbea0fd95b973c7615c,

title = "Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes",

keywords = "PHASE-I TRIAL, ONCOLYTIC ADENOVIRUS, CANCER-PATIENTS, GENE-TRANSFER, CLINICAL-TRIAL, OVARIAN-CANCER, DESMOGLEIN 2, VIRUS, RECEPTOR, FIBER, 3122 Cancers, 3111 Biomedicine, 318 Medical biotechnology, 11832 Microbiology and virology, 1184 Genetics, developmental biology, physiology",

author = "Sadia Zafar and Quixabeira, {Dafne Carolina Alves} and Kudling, {Tatiana Viktorovna} and Victor Cervera-Carrascon and Santos, {Joao Manuel} and Susanna Gr{\"o}nberg-V{\"a}h{\"a}-Koskela and Fang Zhao and Pasi Aronen and Camilla Heini{\"o} and Riikka Havunen and Suvi Sorsa and Anna Kanerva and Akseli Hemminki",

year = "2021",

month = may,

doi = "10.1038/s41417-020-00226-z",

language = "English",

volume = "28",

pages = "442--454",

journal = "Cancer Gene Therapy",

issn = "0929-1903",

publisher = "NATURE PUBLISHING GROUP",

number = "5",

}

Zafar, S, Quixabeira, DCA, Kudling, TV, Cervera-Carrascon, V, Santos, JM, Grönberg-Vähä-Koskela, S, Zhao, F, Aronen, P, Heiniö, C, Havunen, R, Sorsa, S, Kanerva, A & Hemminki, A 2021, 'Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes', Cancer Gene Therapy, Vuosikerta 28, Nro 5, Sivut 442-454. https://doi.org/10.1038/s41417-020-00226-z

TY - JOUR

T1 - Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes

AU - Zafar, Sadia

AU - Quixabeira, Dafne Carolina Alves

AU - Kudling, Tatiana Viktorovna

AU - Cervera-Carrascon, Victor

AU - Santos, Joao Manuel

AU - Grönberg-Vähä-Koskela, Susanna

AU - Zhao, Fang

AU - Aronen, Pasi

AU - Heiniö, Camilla

AU - Havunen, Riikka

AU - Sorsa, Suvi

AU - Kanerva, Anna

AU - Hemminki, Akseli

PY - 2021/5

Y1 - 2021/5

KW - PHASE-I TRIAL

KW - ONCOLYTIC ADENOVIRUS

KW - CANCER-PATIENTS

KW - GENE-TRANSFER

KW - CLINICAL-TRIAL

KW - OVARIAN-CANCER

KW - DESMOGLEIN 2

KW - VIRUS

KW - RECEPTOR

KW - FIBER

KW - 3122 Cancers

KW - 3111 Biomedicine

KW - 318 Medical biotechnology

KW - 11832 Microbiology and virology

KW - 1184 Genetics, developmental biology, physiology

U2 - 10.1038/s41417-020-00226-z

DO - 10.1038/s41417-020-00226-z

M3 - Article

VL - 28

SP - 442

EP - 454

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

SN - 0929-1903

IS - 5

ER -